Regenerative therapies grounded in published science, coordinated by Strong Craft Regen and carried out at Innovita Clinic in Vilnius, Lithuania.
Explore the five treatment areas below. Each image opens the full treatment page.
Mesenchymal stromal cells, often called mesenchymal stem cells or MSCs, are studied for their effects on immune activity and tissue repair. The next-generation approach used by our scientific partner focuses on cell selection and culture methods. Manufacturing aims should be distinguished from demonstrated clinical results.
The treating physician assesses the proposed product, route and evidence for your condition. Results from one MSC preparation cannot be assumed to apply to another, and some uses remain investigational. Learn more about MSC manufacturing and quality.
Exosomes are small particles released by cells that carry proteins, lipids and other biological material. Researchers are investigating how these signals affect inflammation and tissue repair, including whether particular preparations can reach tissues such as the brain.
Those research findings do not establish that an exosome treatment will reach the intended tissue or improve a particular condition in people. The product, route, clinical evidence and regulatory status all need to be considered. Our exosome explainer looks at the evidence.
Peptides are short chains of amino acids. Their actions differ: evidence for one peptide does not establish the benefits or safety of another. Some are approved medicines for specific uses; others are being studied and have limited human evidence.
We help coordinate a discussion of relevant options with the medical team. Assessment includes the exact compound, intended use, interactions and local requirements. Browse the peptide articles to explore individual compounds and their evidence.
IV therapy delivers a preparation directly into the bloodstream. That route alone does not establish a health benefit or make an ingredient suitable for everyone. The clinical question is whether a particular infusion has evidence for your needs.
The medical team reviews the ingredients, dose, medical history and relevant tests before proposing an infusion. Ask about expected benefit, infusion-related risks, alternatives and whether the same goal can be met without an IV.
Biologics is a broad term for products made from biological sources. On this site, it includes discussion of plasma-derived and other preparations considered by our clinical partners. These products can differ substantially in composition and evidence.
A proposed biologic needs to be assessed individually, including its source, testing, intended use and regulatory status. Adding it to a cell or exosome protocol does not by itself establish a better outcome. Ask the team to explain the evidence for the specific combination.